Health Care Equipment & Services

Discover how Privia Health’s insider trades reveal its disciplined governance, AI‑driven physician platform, and growing value‑based care model—insightful for savvy investors.

Insider buying at Oncology Institute Inc. signals strong confidence in its high‑growth oncology services and robust balance sheet, hinting at future upside.

MEDTRONIC insider selling stays small and routine as SVP Walter R. sells 3,102 shares, reflecting liquidity management rather than a market signal.

NewGenIVF insider grant: CEO’s 73,647 ESOs signal confidence, align incentives, and hint at tech upgrades that could boost future value.

ResMed insider trades reveal CEO confidence, MatrixCare sale, and Noctrix acquisition—strategic moves fueling long‑term growth and shareholder value.

Concord Medical’s CFO keeps 477K shares—showing steady confidence amid a volatile market and hinting at future growth potential in China’s radiotherapy sector.

GLAUKOS CFO’s July 6 insider trades show deep‑discount buying, premium selling and option liquidation—indicating strong confidence and strategic capital use for glaucoma therapy growth.

Glaukos insider sale: 716 shares at $139.06 highlights executive trading patterns, market rally, and the firm’s micro‑injectable glaucoma pipeline, reimbursement strategy, and tech adoption.

CEO Sean Duffy’s $22.98 purchase of OMADA Health shares signals insider confidence amid a growing digital‑health boom—an inside look at why this 1.4 B‑dollar stock matters.

Insider sales at Simulations Plus: DiBella sells 1,000 shares at $18.36, part of a pattern of executive divestitures that may signal strategic shifts or portfolio rebalancing.